top of page

Eyes on Pharma
Check-out What Intel Caught our Eye

Jana Chisholm
Jan 206 min read
BioPharma M&A Update
According to an annual PwC study released in December, the amount of M&A activity in the pharmaceutical and life sciences sectors in 2024...

Jana Chisholm
Dec 11, 202416 min read
Eyes on 3Q24 Financial Results
We've highlighted a few firms: Lilly, AbbVie, Pfizer, Novo Nordisk, BMS, Roche, Novartis, Merck, AstraZeneca, GSK, Viatris, Teva, and Amgen.


Jana Chisholm
Nov 17, 20244 min read
Eyes on Sanofi, Regeneron, Novo Nordisk, and Pfizer
We've had Eyes On some of the recent deals, results, and investor actions. Check out the happenings at Sanofi/Opella, Pfizer, Regeneron, and

Jana Chisholm
Feb 8, 20243 min read
Eyes on BioPharma Portfolio Strategies
This week we've had Eyes how BioPharma are bolstering their Portfolios for long-term success. From licensing assets ...

Jana Chisholm
Nov 24, 20233 min read
Eyes on Casgevy, Pfizer & More
Some of this week's news includes Casgevy Approval, Novo's REDEFINE 4 Trial, , new Manufacturing plant and more.
bottom of page